Standard BioTools Inc. (LAB)

Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	270.03	120.86	166.73	51.7	81.31	28.45
Short-Term Investments	206.69	66.71	126.15	63.19	84.48	18.32
Cash & Short-Term Investments	476.72	187.58	292.87	114.9	165.78	46.77
Cash Growth	101.08%	-35.95%	154.91%	-30.70%	254.46%	-31.74%
Accounts Receivable	-	13.43	14.74	19.66	17.28	20.83
Inventory	17.1	19.98	20.74	20.53	21.47	20.83
Other Current Assets	7.3	233.28	47.52	3.13	4.28	4.47
Total Current Assets	516.87	454.26	375.88	158.22	208.82	72.07
Net Property, Plant & Equipment	39.55	46.01	49.34	54.85	59.54	65.15
Other Intangible Assets	-	-	-	1.4	12.6	27.93
Goodwill	-	-	-	106.32	106.25	106.38
Long-Term Investments	67.28	25.7	-	-	-	-
Other Long-Term Assets	3.53	41.78	187.12	2.29	3.11	3.69
Total Assets	627.22	567.75	612.35	323.07	390.31	275.21

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	9.55	5.41	5.05	9.24	7.91	10.6
Accrued Expenses	29.61	29.78	21.44	21.02	15.33	13.59
Short-Term Debt	-	-	-	-	-	6.84
Current Portion of Long-Term Debt	-	-	-	59.53	2.08	-
Current Portion of Leases	5.62	5.49	4.81	4.32	3.68	3.05
Unearned Revenue	2.88	42	13.8	15.22	14.44	15.48
Other Current Liabilities	-	25.63	20.8	-	-	-
Total Current Liabilities	56.8	108.31	65.9	109.33	43.44	49.57
Long-Term Debt	0.3	0.3	0.3	3.98	62.81	64.21
Long-Term Leases	22.17	25.04	25.59	30.37	34.08	37.55
Other Long-Term Liabilities	7.98	9.82	48.84	16.18	20.19	29.29
Total Long-Term Liabilities	30.45	35.16	74.73	50.54	117.08	131.05
Total Liabilities	87.25	143.46	140.62	159.87	160.52	180.62

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.41	0.4	0.4	0.08	0.08	0.08
Treasury Stock	-46.47	-46.47	-46.47	-5.98	-0.56	-
Additional Paid-in Capital	1,745	1,732	1,702	860.82	847.01	831.42
Accumulated Other Comprehensive Income	1.18	-1.49	1.23	-2.22	-1.9	-0.91
Retained Earnings	-1,160	-1,261	-1,186	-1,001	-926.1	-736
Total Common Shareholders' Equity	539.97	424.29	471.72	-148.05	-81.47	94.6
Minority Interest	-	-	-	311.25	311.25	-
Shareholders' Equity	539.97	424.29	471.72	163.2	229.79	94.6
Total Liabilities & Equity	627.22	567.75	612.35	323.07	390.31	275.21

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	28.09	30.83	30.7	98.21	102.66	111.65
Net Cash (Debt)	448.63	156.75	262.18	16.69	63.13	-64.88
Net Cash Growth	115.20%	-40.21%	1471.35%	-73.57%	-	-
Net Cash Per Share	1.16	0.41	0.74	0.21	0.81	-0.83
Book Value	539.97	424.29	471.72	-148.05	-81.47	94.6
Book Value Per Share	1.40	1.11	1.34	-1.87	-1.04	1.21
Tangible Book Value	539.97	424.29	471.72	-255.77	-200.32	-39.71
Tangible Book Value Per Share	1.40	1.11	1.34	-3.23	-2.56	-0.51

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error